231 related articles for article (PubMed ID: 30604893)
1. Metabolic profiling analysis upon acylcarnitines in tissues of hepatocellular carcinoma revealed the inhibited carnitine shuttle system caused by the downregulated carnitine palmitoyltransferase 2.
Lu X; Zhang X; Zhang Y; Zhang K; Zhan C; Shi X; Li Y; Zhao J; Bai Y; Wang Y; Nie H; Li Y
Mol Carcinog; 2019 May; 58(5):749-759. PubMed ID: 30604893
[TBL] [Abstract][Full Text] [Related]
2. CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity.
Fujiwara N; Nakagawa H; Enooku K; Kudo Y; Hayata Y; Nakatsuka T; Tanaka Y; Tateishi R; Hikiba Y; Misumi K; Tanaka M; Hayashi A; Shibahara J; Fukayama M; Arita J; Hasegawa K; Hirschfield H; Hoshida Y; Hirata Y; Otsuka M; Tateishi K; Koike K
Gut; 2018 Aug; 67(8):1493-1504. PubMed ID: 29437870
[TBL] [Abstract][Full Text] [Related]
3. Carnitine palmitoyltransferase 2: New insights on the substrate specificity and implications for acylcarnitine profiling.
Violante S; Ijlst L; van Lenthe H; de Almeida IT; Wanders RJ; Ventura FV
Biochim Biophys Acta; 2010 Sep; 1802(9):728-32. PubMed ID: 20538056
[TBL] [Abstract][Full Text] [Related]
4. Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient.
Violante S; Ijlst L; Te Brinke H; Koster J; Tavares de Almeida I; Wanders RJ; Ventura FV; Houten SM
Biochim Biophys Acta; 2013 Sep; 1831(9):1467-74. PubMed ID: 23850792
[TBL] [Abstract][Full Text] [Related]
5. Loss of Muscle Carnitine Palmitoyltransferase 2 Prevents Diet-Induced Obesity and Insulin Resistance despite Long-Chain Acylcarnitine Accumulation.
Pereyra AS; Rajan A; Ferreira CR; Ellis JM
Cell Rep; 2020 Nov; 33(6):108374. PubMed ID: 33176143
[TBL] [Abstract][Full Text] [Related]
6. Carnitine palmitoyltransferase 2 and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines.
Violante S; Ijlst L; Te Brinke H; Tavares de Almeida I; Wanders RJ; Ventura FV; Houten SM
FASEB J; 2013 May; 27(5):2039-44. PubMed ID: 23322164
[TBL] [Abstract][Full Text] [Related]
7. CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer.
Liu Y; Wang F; Yan G; Tong Y; Guo W; Li S; Qian Y; Li Q; Shu Y; Zhang L; Zhang Y; Xia Q
Cancer Lett; 2024 Jul; 595():217006. PubMed ID: 38823763
[TBL] [Abstract][Full Text] [Related]
8. E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment.
González-Romero F; Mestre D; Aurrekoetxea I; O'Rourke CJ; Andersen JB; Woodhoo A; Tamayo-Caro M; Varela-Rey M; Palomo-Irigoyen M; Gómez-Santos B; de Urturi DS; Núñez-García M; García-Rodríguez JL; Fernández-Ares L; Buqué X; Iglesias-Ara A; Bernales I; De Juan VG; Delgado TC; Goikoetxea-Usandizaga N; Lee R; Bhanot S; Delgado I; Perugorria MJ; Errazti G; Mosteiro L; Gaztambide S; Martinez de la Piscina I; Iruzubieta P; Crespo J; Banales JM; Martínez-Chantar ML; Castaño L; Zubiaga AM; Aspichueta P
Cancer Res; 2021 Jun; 81(11):2874-2887. PubMed ID: 33771899
[TBL] [Abstract][Full Text] [Related]
9. Substrate specificity of human carnitine acetyltransferase: Implications for fatty acid and branched-chain amino acid metabolism.
Violante S; Ijlst L; Ruiter J; Koster J; van Lenthe H; Duran M; de Almeida IT; Wanders RJ; Houten SM; Ventura FV
Biochim Biophys Acta; 2013 Jun; 1832(6):773-9. PubMed ID: 23485643
[TBL] [Abstract][Full Text] [Related]
10. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics.
Huang Q; Tan Y; Yin P; Ye G; Gao P; Lu X; Wang H; Xu G
Cancer Res; 2013 Aug; 73(16):4992-5002. PubMed ID: 23824744
[TBL] [Abstract][Full Text] [Related]
11. Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma.
Enooku K; Nakagawa H; Fujiwara N; Kondo M; Minami T; Hoshida Y; Shibahara J; Tateishi R; Koike K
Sci Rep; 2019 Jul; 9(1):10663. PubMed ID: 31337855
[TBL] [Abstract][Full Text] [Related]
12. Developmental regulation and localization of carnitine palmitoyltransferases (CPTs) in rat brain.
Jernberg JN; Bowman CE; Wolfgang MJ; Scafidi S
J Neurochem; 2017 Aug; 142(3):407-419. PubMed ID: 28512781
[TBL] [Abstract][Full Text] [Related]
13. NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma.
Zhang S; Li J; Wang X
Tumour Biol; 2016 Oct; 37(10):14059-14067. PubMed ID: 27507614
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of CPT2 promotes tumorigenesis and chemoresistance to cisplatin in hepatocellular carcinoma.
Lin M; Lv D; Zheng Y; Wu M; Xu C; Zhang Q; Wu L
Onco Targets Ther; 2018; 11():3101-3110. PubMed ID: 29872321
[TBL] [Abstract][Full Text] [Related]
16. Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases.
Zhou L; Wang Q; Yin P; Xing W; Wu Z; Chen S; Lu X; Zhang Y; Lin X; Xu G
Anal Bioanal Chem; 2012 Apr; 403(1):203-13. PubMed ID: 22349331
[TBL] [Abstract][Full Text] [Related]
17. Octanoate is differentially metabolized in liver and muscle and fails to rescue cardiomyopathy in CPT2 deficiency.
Pereyra AS; Harris KL; Soepriatna AH; Waterbury QA; Bharathi SS; Zhang Y; Fisher-Wellman KH; Goergen CJ; Goetzman ES; Ellis JM
J Lipid Res; 2021; 62():100069. PubMed ID: 33757734
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator activated receptor delta (PPARdelta) agonist but not PPARalpha corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells.
Djouadi F; Aubey F; Schlemmer D; Bastin J
J Clin Endocrinol Metab; 2005 Mar; 90(3):1791-7. PubMed ID: 15613406
[TBL] [Abstract][Full Text] [Related]
19. Carnitine palmitoyltransferase 2 deficiency: the time-course of blood and urinary acylcarnitine levels during initial L-carnitine supplementation.
Hori T; Fukao T; Kobayashi H; Teramoto T; Takayanagi M; Hasegawa Y; Yasuno T; Yamaguchi S; Kondo N
Tohoku J Exp Med; 2010 Jul; 221(3):191-5. PubMed ID: 20543534
[TBL] [Abstract][Full Text] [Related]
20. Carnitine palmitoyltransferase gene upregulation by linoleic acid induces CD4
Brown ZJ; Fu Q; Ma C; Kruhlak M; Zhang H; Luo J; Heinrich B; Yu SJ; Zhang Q; Wilson A; Shi ZD; Swenson R; Greten TF
Cell Death Dis; 2018 May; 9(6):620. PubMed ID: 29795111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
